The University has signed a licence agreement with life sciences giant Merck for pioneering fluorescent probe technology that helps understand how disease progresses.
ERI has concluded a licence deal with sustainability software and data company Ecometrica for software developed at the University of Edinburgh.
Salmon breeding performance for Landcatch Natural Selection has vastly improved with long term research support from the University’s Roslin Institute.
The University has licensed a revolutionary technology for remediation of contaminated soil and groundwater to Geosyntec Consultants, Inc., a US-based geo-engineering firm.
An innovative research tool developed at the University is being utilised by a leading research reagent company to create products that will help life scientists to understand Cancer, Rett Syndrome and, possibly, other disorders.
When Professor Ken Murray licensed his pioneering Hepatitis B vaccine to a US biotechnology company in the 1980s, no-one could have predicted the global impact of his discovery or the contribution that the royalty income would make to future education and research at the University.